Vertex Pharmaceuticals Incorporated shares owned by New England Research & Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by New England Research & Management
from 13F filings
Historical chart of New England Research & Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by New England Research & Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Vertex Pharmaceuticals Incorporated by New England Research & Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $601k | 1.5k | 391.64 |
| 2025-06-30 | $472k | 1.1k | 445.28 |
| 2024-09-30 | $2.1M | 4.6k | 465.14 |
| 2024-06-30 | $1.3M | 2.7k | 468.74 |
| 2024-03-31 | $1.2M | 2.8k | 417.99 |
| 2023-03-31 | $780k | 2.5k | 315.15 |
| 2022-12-31 | $274k | 950 | 288.42 |
| 2019-09-30 | $462k | 2.7k | 169.54 |
| 2019-06-30 | $431k | 2.4k | 183.40 |
| 2019-03-31 | $230k | 1.3k | 184.00 |
More positions owned by New England Research & Management
View all positions for New England Research & Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated